Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Purchased by Alberta Investment Management Corp

Alberta Investment Management Corp increased its position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP) by 15.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,447 shares of the company’s stock after purchasing an additional 589 shares during the quarter. Alberta Investment Management Corp’s holdings in Medpace were worth $1,477,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MEDP. R Squared Ltd acquired a new stake in shares of Medpace in the fourth quarter valued at about $30,000. Stone House Investment Management LLC purchased a new stake in Medpace during the 3rd quarter valued at about $33,000. Ashton Thomas Securities LLC acquired a new stake in Medpace in the 3rd quarter valued at about $37,000. Capital Performance Advisors LLP purchased a new position in Medpace in the 3rd quarter worth approximately $46,000. Finally, True Wealth Design LLC boosted its holdings in shares of Medpace by 16,800.0% during the 3rd quarter. True Wealth Design LLC now owns 169 shares of the company’s stock worth $56,000 after purchasing an additional 168 shares during the last quarter. Hedge funds and other institutional investors own 77.98% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Robert W. Baird increased their price target on Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, Medpace currently has an average rating of “Hold” and a consensus price target of $381.44.

Medpace Stock Performance

Shares of Medpace stock opened at $340.78 on Friday. The stock has a 50 day moving average of $343.23 and a 200 day moving average of $347.46. The firm has a market capitalization of $10.38 billion, a price-to-earnings ratio of 26.98, a PEG ratio of 3.80 and a beta of 1.36. Medpace Holdings, Inc. has a fifty-two week low of $302.01 and a fifty-two week high of $459.77.

Medpace (NASDAQ:MEDP) last released its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. Analysts forecast that Medpace Holdings, Inc. will post 12.29 EPS for the current year.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.